Hamid Abkarali

Title: The Innovations of Hamid Abkarali

Introduction

Hamid Abkarali is an accomplished inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmacology, particularly in the development of opioid receptor modulators. His work is crucial in addressing the challenges associated with opioid addiction and pain management.

Latest Patents

Abkarali holds a patent for "Potent and selective mu opioid receptor modulators." This patent includes analogues of 6 α/β-naltrexamine (NAQ), which are identified as selective, reversible antagonists of the mu opioid receptor (MOR). These compounds demonstrate good blood-brain barrier penetration and are utilized in the treatment of opioid addiction and various diseases, including pain management. He has 1 patent to his name.

Career Highlights

Hamid Abkarali is affiliated with Virginia Commonwealth University, where he conducts research and develops innovative solutions in the field of opioid receptor modulation. His work has garnered attention for its potential impact on public health and the treatment of addiction.

Collaborations

Abkarali collaborates with notable colleagues, including Yan Zhang and Dana E Selley, to advance research in his field. Their combined expertise contributes to the development of effective therapeutic strategies.

Conclusion

Hamid Abkarali's contributions to the field of pharmacology, particularly through his patent on mu opioid receptor modulators, highlight his role as an innovative inventor. His work is essential in the ongoing fight against opioid addiction and pain management.